NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative ...
"Prof. Valmed", an AI-supported chatbot for the medical sector, is the first class IIb medical language AI to receive approval. The system uses a large language model to search for specific validated ...
OS Therapies’ cancer vaccine, OST-HER2, has been shown to significantly improve overall survival (OS) in patients with recurrent, fully resected, pulmonary metastatic osteosarcoma after two years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback